The therapeutic properties of Carapa guianensis

Current Pharmaceutical Design

Volumn 20, Issue 6, 2014, Pages 850-856

  Henriques, Maria das Graças ^a,b   Penido, Carmen ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Instituto Nacional de Ciência e Tecnologia de Gestão da Inovação em Doenças Negligenciadas INCT IDN   (Brazil)

Author keywords

Allergy; Andiroba; Cytokines; Eosinophils; Inflammation; Leukocytes; Limonoids; Tetranortriterpenoids

Indexed keywords

ANTIALLERGIC AGENT; ANTIINFLAMMATORY AGENT; BRADYKININ; CARAPA GUIANENSIS EXTRACT; EOTAXIN; GEDUNIN; HISTAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 5; PLANT EXTRACT; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

CARAPA GUIANENSIS; CELL DIFFERENTIATION; CELL POPULATION; DRUG STRUCTURE; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY DISEASE; MELIACEAE; NONHUMAN; PLANT SEED; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS; BRAZIL; HUMANS; HYPERSENSITIVITY; INFLAMMATION; MEDICINE, TRADITIONAL; MELIACEAE; PLANT OILS;

EID: 84895084891     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990048     Document Type: Review

References (83)

1. Sumner J. 2000. The Natural History of Medicinal Plants. Oregon: Timber Press.
2. Pinto PG. 1963. Características Físico-Químicas e Outras Informações Sobre as Principais Oleaginosas do Brasil. Boletim Técnico. 18. Ministério da Agricultura, Recife/PE, Brasil.
3. Pennington TD, Stules BT, Taylor DAH. Meliaceae. Fl Neotrop 1981; 28: 406-19.
4. Hammer MLA, Johns EA. Tapping an Amazonian plethora: four medicinal plants of Marajo Island, Pará (Brazil). J Ethnopharmacol 1993; 40: 53-75.
5. Ferraz IDK, Camargo JLC, Sampaio PTB. Sementes e plântulas de andiroba (Carapa guianensis AUBL. e Carapa procera D. C.): aspectos botânicos, ecológicos e tecnológicos. Acta Amaz 2002; 32: 647-61.
6. Ferraz IDK. 2003. Andiroba-Carapa guianensis Aubl. Informativo Técnico Rede de Sementes da Amazônia No 1.
7. Forget PM, Kenfack D. 2008 Carapa.org. A website dedicated to trees in the genus Carapa (Meliaceae). Taxinomy, biology, ecology and uses. Muséum National d'Histoire Naturelle, Brunoy, France.
8. Kenfack D. A synoptic revision of Carapa (Meliaceae). Harv Pap Bot 2011; 16(2): 171-231.
9. Taylor L. 2005. The Healing Power of Rainforest Herbs A Guide to Understanding and Using Herbal Medicinals, New York: Square One Publishers, Inc.
10. Coelho-Ferreira M. Medicinal knowledge and plant utilization in an Amazonian coastal community of Marudá, Pará State (Brazil) J Ethnopharmacol 2009; 126: 159-75.
11. Rodrigues E. Plants and animals utilized as medicines in the Jaú National Park (JNP), Brazilian Amazon, Phytother Res 2006; 20: 378-91.
12. Rodrigues E, Duarte-Almeida JM, Pires JM. Perfil farmacológico e fitoquímico de plantas indicadas pelos caboclos do Parque Nacional do Jaú (AM) como potenciais analgésicas. Parte I. Revista Brasileira de Farmacognosia. Braz J Pharmacogn 2010; 20(6): 981-91.
13. Luz FJF. Plantas medicinais de uso popular em Boa Vista, Roraima, Brasil. Horticultura Brasileira, Brasília, 2001; 19(1): 88-96.
14. Silva AL, Tamashiro J, Begossi A. Ethnobotany of riverine populations from Rio Negro, Amazonia (Brasil). J Ethnobiol 2007; 27(1): 46-72.
15. Ollis WD, Ward A, Dmeirelles de Oliveira H, Zelkin R. Andirobin. Tetrahedron 1970; 26: 1637-43.
16. Ollis WD, Ward AD. Andirobin. Tetrahedron Lett 1964; 37: 2607-14.
17. Lavie D, Levy EC, Zelnik R. The constituents of Carapa guianensis Aubl. and their biogenetic relationship. Bioorg Chem 1972; 2: 59-64.
18. Champagne DE, Koul O, Isman MB, Scudder GGE, Towers GHN. Biological activity of limonoids from the rutales. Phytochemistry 1992; 31: 377-94.
19. Bandaranayake WM. Bioactivities, bioactive compounds and chemical constituents of mangrove plants. Wetl Ecol Manag 2002; 10: 421-52.
20. Connolly JD, Mccrindler R, Overton KH, Feeney J. Tetranortriterpenoids-II: Heartwood constituents of Carapa guianensis Aubl. Tetrahedron 1966; 22: 891-96.
21. Pereira JFG, Mazzei, JL, Gilbert B. Characterization of the chemical constituents of Carapa guianenses Aublet by HPLCDAD. Boll Chim Farmaceutico 1999; 138(2): 177.
22. Marcelle G, Mootoo, B. Tetranortripenoids from the heartwood of Carapa guianensis. Phytochemistry 1975; 14: 2717-8.
23. Ambrozin ARP, Leite AC, Bueno FC, et al. Limonoids from andiroba oil and Cedrela fissilis and their insecticidal activity. J Braz Chem Soc 2006; 17(3): 542-7.
24. Silva VP, Rodrigues RO, Figueiredo MR. Isolation of limonoids from seeds of Carapa guianensis Aublet (Meliaceae) by high-speed countercurrent chromatography. Phytochem Anal 2009; 20(1): 77-81.
25. Silva SG, Nunomura RCS. Limonoides isolados dos frutos de Carapa guianensis Aublet (Meliaceae) Quim Nova 2012; 35(10): 1936-9.
26. Tanaka Y, Yamada T, In Y, Muraoka O, Kajimoto T, Tanaka R. Absolute stereostructure of Andirolides A-G from the flower of Carapa guianensis (Meliaceae). Tetrahedron 2011; 67: 782-92.
27. Tanaka Y, Sakamoto A, Inoue T, et al. Andirolides H-P from the lower of andiroba (Carapa guianensis, Meliaceae). Tetrahedron 2012; 68: 3669-77.
28. Inoue T, Nagai Y, Mitooka A, et al. Carapanolides A and B: unusual 9,10-seco-mexicanolides having 2R,9S-oxygen bridge from the seeds of Carapa guianensis. Tetrahedron Lett 2012; 53: 6685-8.
29. Penido C, Costa KA, Pennaforte RJ, et al. Anti-allergic effects of natural tetranortriterpenoids isolated from Carapa guianensis Aublet on allergen-induced vascular permeability and hyperalgesia. Inflamm Res 2005; 54(7): 295-303.
30. Penido C, Costa KA, Costa MF, Pereira JF, Siani AC, Henriques MG. Inhibition of allergen-induced eosinophil recruitment by natural tetranortriterpenoids is mediated by the suppression of IL-5, CCL11/eotaxin and NF-κB activation. Int Immunopharmacol 2006; 6(2): 109-21.
31. Penido C, Conte FP, Chagas MS, Rodrigues CA, Pereira JF, Henriques MG. Antiinflammatory effects of natural tetranortriterpenoids isolated from Carapa guianensis Aublet on zymosan-induced arthritis in mice. Inflamm Res 2006; 55(11): 457-64.
32. Ferraris FK, Rodrigues R, da Silva VP, Figueiredo R, Penido C, Henriques MG. Modulation of T lymphocyte and eosinophil functions in vitro by natural tetranortriterpenoids isolated from Carapa guianensis Aublet. Int Immunopharmacol 2011; 11(1): 1-11.
33. Carey MA, Germolec DR, Langenbach R, Zeldin DC. Cyclooxygenase enzymes in allergic inflammation and asthma. Prostaglandins Leukot Essent Fatty Acids 2003; 69(2-3): 157-62.
34. Nayak BS, Kanhai J, Milne DM, et al. Investigation of the wound healing activity of Carapa guianensis L. (Meliaceae) bark extract in rats using excision, incision, and dead space wound models. J Med Food 2010; 13(5): 1141-6.
35. Nayak BS, Kanhai J, Milne DM, Pinto Pereira L, Swanston WH. Experimental Evaluation of Ethanolic Extract of Carapa guianensis L. Leaf for Its Wound Healing Activity Using Three Wound Models. Evid Based Complement Alternat Med 2011; 2011: 419612.
36. Cazal CM, Choosang K, Severino VG, et al. Evaluation of effect of triterpenes and limonoids on cell growth, cell cycle and apoptosis in human tumor cell line. Anticancer Agents Med Chem 2010; 10(10): 769-76.
37. Kamath SG, Chen N, Xiong Y, et al. Gedunin, a novel natural substance, inhibits ovarian cancer cell proliferation. Int J Gynecol Cancer 2009; 19(9):1564-9.
38. Uddin SJ, Nahar L, Shilpi JA, et al. Gedunin, a limonoid from Xylocarpus granatum, inhibits the growth of CaCo-2 colon cancer cell line in vitro. Phytother Res 2007; 21(8): 757-61.
39. Patwardhan CA, Fauq A, Peterson LB, Miller C, Blagg BS, Chadli A. Gedunin Inactivates the Co-chaperone p23 Causing Cancer Cell Death by Apoptosis. J Biol Chem 2013 [in press]
40. Jang SW, Liu X, Chan CB, et al. Deoxygedunin, a natural product with potent neurotrophic activity in mice. PLoS One 2010; 5(7): e11528.
41. MacKinnon S, Durst T, Arnason JT, et al. Antimalarial activity of tropical Meliaceae extracts and gedunin derivatives. J Nat Prod 1997; 60(4): 336-41.
42. Mitsui K, Saito H, Yamamura R, Fukaya H, Hitotsuyanagi Y, Takeya K. Hydroxylated gedunin derivatives from Cedrela sinensis. J Nat Prod 2006; 69(9): 1310-4.
43. Ferraris FK, Moret KH, Figueiredo AB, Penido C, Henriques MG. Gedunin, a natural tetranortriterpenoid, modulates T lymphocyte responses and ameliorates allergic inflammation. Int Immunopharmacol 2012; 14(1): 82-93.
44. Nathan SS, Kalaivani K, Chung PG, Murugan K. Effect of neem limonoids on lactate dehydrogenase (LDH) of the rice leafholder, Cnaphalocrocis medinalis (Guenee) (Insecta: Lepidoptera: Pyralidae). Chemosphere 2006; 62: 1388-93.
45. Khalid SA, Duddeck H, Gonzalez-Sierra M. Isolation and characterization of an antimalarial agent of the neem tree Azadirachta indica. J Nat Prod 1989; 52: 922-7.
46. Lamb J, Crawford ED, Peck D, et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006; 313: 1929-35.
47. Hieronymus H, Lamb J, Ross KN, et al. Gene expression signaturebased chemical genomic prediction identifies a novel class of Hsp90 pathway modulators. Cancer Cell 2006; 10: 321-30.
48. Whitesell L, Lindquist SL. HSP90 and the chaperoning of cancer. Nat Rev Cancer 2005; 5: 761-72.
49. Pratt WB, Toft DO. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 2003; 228: 111-33.
50. Whitesell L, Santagata S, Lin NU. Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution. Curr Mol Med 2012; 12(9): 1108-24.
51. Neckers L. Heat shock protein 90: the cancer chaperone. J Biosci 2007; 32: 517-30.
52. Xiao L, Lu X, Ruden DM. Effectiveness of Hsp90 inhibitors as anti-cancer drugs. Mini-Rev Med Chem 2006; 6: 1137-43.
53. Isaacs JS, Xu W, Neckers L. Heat shock protein 90 as a molecular target for cancer theapeutics. Cancer Cell 2003; 3: 213-7.
54. Maloney A, Workman P. Hsp90 as a new therapeutic target for cancer therapy: the story unfolds. Expert Opin Biol Ther 2002; 2: 3-24.
55. Yeo M, Park HK, Lee KM, et al. Blockage of HSP 90 modulates Helicobacter pylori-induced IL-8 productions through the inactivation of transcriptional factors of AP-1 and NF-κB. Biochem Biophys Res Commun 2004; 320: 816-24.
56. Hsu HY, Wu HL, Tan SK, et al. Geldanamycin interferes with the 90-kDa heat shock protein, affecting lipopolysaccharide-mediated interleukin-1 expression and apoptosis within macrophages. Mol Pharmacol 2007; 71: 344-56.
57. Chatterjee A, Wheeler D, Dimitropoulou C, Catravas JD. The geldanamycin derivative, 17-AAG, improves survival and attenuates inflammation in sepsis. Am J Respir Crit Care Med 2007; 175: A30.
58. Dimitropoulou C, Drakopanagiotakis F, Chatterjee A, Snead C, Catravas JD. Hsp90 inhibitors ameliorate pulmonary dysfunction in acute lung injury. Am J Respir Crit Care Med 2007; 175: A838.
59. Poulaki V, Iliaki E, Mitsiades N, et al. Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis. FASEB J 2007; 21: 2113-23.
60. Madrigal-Matute J, López-Franco O, Blanco-Colio LM, et al. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis. Cardiovasc Res 2010; 86: 330-7.
61. Lewis J, Devin A, Miller A, et al. Disruption of hsp90 function results in degradation of the death domain kinase, receptorinteracting protein (RIP), and blockage of tumor necrosis factorinduced nuclear factorB activation. J Biol Chem 2000; 275: 10519-26.
62. Broemer M, Krappmann D, Scheidereit C. Requirement of Hsp90 activity for I B kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation. Oncogene 2004; 23: 5378-86.
63. Pittet JF, Lee H, Pespeni M, O'Mahony A, Roux J, Welch WJ. Stress-induced inhibition of the NF-κB signaling pathway results from the insolubilization of the I B kinase complex following its dissociation from heat shock protein 90. J Immunol 2005; 174: 384-94.
64. Kastelic T, Schnyder J, Leutwiler A, et al. Induction of rapid IL-1 mRNA degradation in THP-1 cells mediated through the AU-rich region in the 3'UTR by a radicicol analogue. Cytokine 1996; 8: 751-61.
65. Wax S, Piecyk M, Maritim B, Anderson P. Geldanamycin inhibits the production of inflammatory cytokines in activated macrophages by reducing the stability and translation of cytokine transcripts. Arthritis Rheum 2003; 48: 541-50.
66. Adcock IM, Chung KF, Caramori G, Ito K. Kinase inhibitors and airway inflammation. Eur J Pharmacol 2006; 533(1-3): 118-32.
67. Sato S, Fujita N, Tsuruo T. Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci USA 2000; 97: 10832-37.
68. Wei Q, Xia Y. Roles of 3-phosphoinositide-dependent kinase 1 in the regulation of endothelial nitric-oxide synthase phosphorylation and function by heat shock protein 90. J Biol Chem 2005; 280: 18081-6.
69. Rice JW, Veal JM, Fadden RP, et al. Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis. Arthritis Rheum 2008; 58(12): 3765-75.
70. Williams LT. Signal transduction by the platelet-derived growth factor receptor. Science 1989; 243(4898): 1564-70.
71. Matei D, Satpathy M, Cao L, Lai YC, Nakshatri H, Donner DB. The platelet-derived growth factor receptor is destabilized by geldanamycins in cancer cells. J Biol Chem 2007; 282: 445-53.
72. Lewis CC, Chu HW, Westcott JY, et al. Increased expression of platelet-derived growth factor receptor-beta in airway fibroblasts of severe asthmatics. Chest 2003; 123(3 Suppl): 428S-9S
73. Wong WS. Inhibitors of the tyrosine kinase signaling cascade for asthma. Curr Opin Pharmacol 2005; 5(3): 264-71.
74. Yamada Y, Cancelas JA. FIP1L1/PDGFR alpha-associated systemic mastocytosis. Int Arch Allergy Immunol 2010; 152 Suppl 1: 101-5.
75. Prodromou C. The 'active life' of Hsp90 complexes. Biochim Biophys Acta 2012; 1823(3): 614-23.
76. Hieronymus H, Lamb J, Ross KN, et al. Gene expression signaturebased chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell 2006; 10: 321-30.
77. Brandt GE, Schmidt MD, Prisinzano TE, Blagg BS. Gedunin, a novel hsp90 inhibitor: semisynthesis of derivatives and preliminary structure-activity relationships. J Med Chem 2008; 51(20): 6495-502.
78. Pacey S, Banerji U, Judson I, Workman P. Hsp90 inhibitors in the clinic. Handb Exp Pharmacol 2006; 172: 331-58.
79. Gorska M, Popowska U, Sielicka-Dudzin A, et al. Geldanamycin and its derivatives as Hsp90 inhibitors. Front Biosci 2012; 17: 2269-77.
80. Costa-Silva JH, Lyra MMA, Lima CR, et al. A toxicological evaluation of the effect of Carapa guianensis Aublet on pregnancy in Wistar rats. J Ethnopharmacol 2007; 112: 122-6.
81. Costa-Silva JH, Lima CR, Silva EJR, et al. Acute and subacute toxicity of the Carapa guianensis Aublet (Meliaceae) seed oil. J Ethnopharmacol 2008; 116: 495-500.
82. Compalati E, Baena-Cagnani R, Penagos M, et al. Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Int Arch Allergy Immunol 2011; 156(1): 1-15.
83. Tkachyk SJ. New treatments for allergic rhinitis. Can Fam Physician. 1999; 45: 1255-60.